Intratumoral cDC1 attract T cells (Spranger et al., 2017), re-stimulate and expand tumor-specific CD8+ T cells (Broz et al., 2014), and support T cell effector function by secreting interleukin (IL)-12 (Ruffell et al., 2014). Here, CD8A is linked to neoplasm.